Literature DB >> 10596908

Genes involved in melanoma: an overview of INK4a and other loci.

M Castellano1, G Parmiani.   

Abstract

Melanoma is the most aggressive of the skin cancers and its prognosis is often poor. The only known environmental risk factor for this tumour is ultraviolet light exposure. This fact together with the existence of melanoma-prone families has prompted investigation of genetic risk factors that may be involved in melanoma development. Inactivation of the INK4a/p16 gene is known to play a role in familial cases. Data on genes or loci involved in sporadic melanoma are less definitive and require more detailed research. In addition to the INK4a locus, other genes involved in melanoma development are discussed here, in particular those genes that participate in the same functional pathway, such as CDK4 and Rb, and p53, which is regulated by the alternative product of INK4a. Evidence showing the possible location of melanoma susceptibility genes on chromosomes 1p, 6, 10q and 11q is analysed along with data showing N-ras, betacatenin, c-myc and MC1R involvement. Melanoma is a well-characterized disease in terms of its progression stages; therefore obtaining precise genetic information is crucial in the development of a stepwise model of melanoma pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10596908

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  12 in total

1.  Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p.

Authors:  Z Adám; R Adány; A Ladányi; J Tímár; M Balázs
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.

Authors:  Matthew W VanBrocklin; James P Robinson; Kristin J Lastwika; Joseph D Khoury; Sheri L Holmen
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-23       Impact factor: 4.693

Review 3.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 4.  Transcription factors and other dysregulated proteins in melanoma prognosis.

Authors:  J M Karjalainen
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

Review 5.  Role of nuclear factor-kappa B in melanoma.

Authors:  Katayoun I Amiri; Ann Richmond
Journal:  Cancer Metastasis Rev       Date:  2005-06       Impact factor: 9.264

Review 6.  NF-kappaB activation in melanoma.

Authors:  Yukiko Ueda; Ann Richmond
Journal:  Pigment Cell Res       Date:  2006-04

7.  Born to be alive: a role for the BCL-2 family in melanoma tumor cell survival, apoptosis, and treatment.

Authors:  Rina A Anvekar; James J Asciolla; Derek J Missert; Jerry E Chipuk
Journal:  Front Oncol       Date:  2011-10-13       Impact factor: 6.244

8.  Towards a Better Understanding of the Molecular Mechanisms Involved in Sunlight-Induced Melanoma.

Authors:  Mandy Williams; Allal Ouhtit
Journal:  J Biomed Biotechnol       Date:  2005

9.  Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).

Authors:  S M Langezaal; J F Graadt van Roggen; A M Cleton-Jansen; J J Baelde; P C Hogendoorn
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

10.  CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.

Authors:  G Della Torre; B Pasini; S Frigerio; R Donghi; D Rovini; D Delia; G Peters; T J Huot; G Bianchi-Scarra; F Lantieri; M Rodolfo; G Parmiani; M A Pierotti
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.